4-HO-MiPT fumarate is a research chemical from the tryptamine class known as 4-hydroxy-N-methyl-N-isopropyltryptamine. It is a structural analogue of other hydroxyltryptamines and is often used in scientific studies to investigate its chemical properties and possible interactions with biological systems. The fumarate form makes the substance more stable and more easily soluble, making it suitable for controlled laboratory experiments and analytical research.
-20%
4-HO-MiPT fumarate
From €22,80
| QUANTITY | DISCOUNT | PRICE |
|---|---|---|
| 0.25 | ||
| 0.50 | ||
| 1 | ||
| 2 | ||
| 5 | ||
| 10 | ||
| 25 | ||
| 50 | ||
| 100 |
Description
Additional information
| Quantity |
0.25 grams ,0.50 grams ,1 gram ,2 grams ,5 grams ,10 grams ,25 grams ,50 grams ,100 grams |
|---|---|
| RC Type |
crystal/powder |
Reviews (0)
Only logged in customers who have purchased this product can write a review.
Related products
Bromazolam 2.5mg Pellets
From €13,95
Select options
This product has several variations. This option can be selected on the product page
2F-Ketamine crystals (2F-DCK)
From €23,95
Select options
This product has several variations. This option can be selected on the product page
Ethyl-Pentedrone crystal (NEP)
From €9,95
Select options
This product has several variations. This option can be selected on the product page
1cP-LSD 150mcg art blotter
From €6,45
Select options
This product has several variations. This option can be selected on the product page
2-MMC crystal chunks
From €9,95
Select options
This product has several variations. This option can be selected on the product page
Norflurazepam pellets 5mg – Blister
From €8,95
Select options
This product has several variations. This option can be selected on the product page
Pyrazolam pellets 2.5mg
From €13,95
Select options
This product has several variations. This option can be selected on the product page
1V-LSD 225mcg Pellets
From €9,95
Select options
This product has several variations. This option can be selected on the product page
Reviews
There are no reviews yet.